First Bioresorbable Vascular Scaffold Implantation in Patients with Acute Coronary Syndrome in the Republic of Macedonia
References
- 1. Maseri A. Ischemic Heart Disease, New York, Churchill Livingstone. 1995; 713.
- 2. World Health Organization; Atlas of Heart Disease and Stroke. Deaths from Coronary Heart Disease. [2011].
- 3. Strong K, et al. Preventing chronic diseases: how many lives can we save? Lancet. 2005; 366(9496): p. 1578-82.
- 4. Gaziano TA, et al., Growing epidemic of coronary heart disease in low and middle-income countries. Curr Probl Cardiol. 2010; 35(2): p. 72-115.
- 5. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992; 326: 242.
- 6. Ross R, Fuster V. The patogenesis of atherosclerosis. In Fuster V, Ross R, Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott- Raven. 1996; 441-462.
- 7. De Vreede JJM, Gorgels APM, Verstraaten GMP, et al. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol. 1991; 18: 698.
- 8. Rentrop KP. Restoration of anterograde flow in acute myocardial infarction: The first 15 years. J Am Coll Cardiol. 1995; 25: 1S.
- 9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351): 13-20.
- 10. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011; 32(15): 1854-1864 (Epub 2011 Jun 29).
- 11. Elbarouni B, Elmanfuld O, Yan RT, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J. 2010; 160(3): 420-427.
- 12. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364: 226-235.
- 13. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362: 2155-2165.
- 14. Fox KA, Eagle KA, Gore JM, et al. The Global Registry of Acute Coronary Events, 1999 to 2009 - GRACE. Heart. 2010; 96: 1095-1101.
- 15. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999; 281: 707-713.
- 16. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006; 27: 2285-2293.
- 17. Dubois C, Pierard LA, Smeets JP, et al. Short and long term prognostic importance of complete bundle branch complicating acute myocardial infarction. Clin Cardiol. 1988; 11: 292.
- 18. Bjerregaard P, Gussak I, Kotar SL, et al. Recurrent syncope in a patient with prominent J wave. Am Heart J. 1994; 127: 1426.
- 19. Braunwald E. The open-artery theory is alive and well - again. N Engl J Med. 1993; 329: 1650.
- 20. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. Am Coll Cardiol. 1992; 20: 1391.
- 21. Cannon A, Freedman SB, Bailey BP, et al. ST-segment changes during transmural myocardial ischemia in chronic left bundle branch block. Am J Cardiol. 1989; 64: 1216.
- 22. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndrome. Am J Cardiol. 1989; 63: 114E.
- 23. Fallon JT. Pathology of myocardial infarction and reperfusion. In Fuster V, Ross R, and Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven. 1996; 791-796.
- 24. Fesmire FM. ECG diagnosis of acute myocardial infarction in the presence of left bundle-branch block in patients undergoing continuous ECG monitoring. Ann Emerg Med. 1995; 26: 69-82.
- 25. Flowers NC. Left bundle branch block: A continuously evolving concept. J Am Coll Cardiol. 1987; 9: 684.
- 26. Forrester JS, Wyatt HL, Daluz, PL, et al. Functional significance of regional ischaemic contraction abnormalities. Circulation. 1976; 54: 64.
- 27. Hands ME, Cook EF, Stone PH, et al. Electrocardiographic diagnosis of myocardial infarction in the presence of complete bundle branch block. Am Heart J. 1988; 116: 23.
- 28. Lamas GA, Mueller JE, Turi AG, et al. A simplified method to predict occurence of complete heart block during acute myocardial infarction. Am J Cardiol. 1986; 57: 1213.
- 29. Mullins CB, Atkins JM. Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis. 1976; 45: 129.
- 30. Oreto G, Saporito F, Donato G, et al. The "Inverse" R wave progression in inferior leads in the presence of left anterior hemiblock: A clinical study. J Electrocardiol. 1991; 24: 277.
- 31. Ricou F, Nicod P, Gilpin E, et al. Influence of right bundle branch block on short and long term survival after acute anterior myocardial infarction. J Am Coll Cardiol. 1991; 17: 858.
- 32. Rosenbaum MB, Girotti LA, Lazzari JO, et al. Abnormal Q waves in right sided chest leads provoked by onset of right bundle branch block in patients with antero-septal infarction. Br Heart J. 1982; 47: 227.
- 33. Scheinman MM, Gonzales RP. Fascicular block and acute myocardial infarction. JAMA. 1980; 244: 2646.
- 34. Schuster EH, Bulkley BH. Ischemia at a distance after acute myocardial infarction: A cause of early postinfarction angina. Circulation. 1980; 62: 509.
- 35. Watt TBJr, Freud GE, Durrer D, et al. Left anterior arborization block combined with right bundle branch block in canine and primate hearts. An electrocardiographic study. Circ Res. 1968; 22: 57.
- 36. White HD, Norris RM, Brown MA, et al. Left ventricular end sistolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76: 44.
- 37. Willems JL, Robles de Medina E, Bernard R, et al. WHO task force on criteria for intraventricular conduction disturbances and pre-excitation. J Am Coll Cardiol. 1985; 5: 1261.
- 38. Brilakis E, Wright S, Kopecky S, et al. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001; 88: 205-209.
- 39. Go AS, Barron HV, Rundle AC, et al. Bundle branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med. 1998; 129: 690-697.
- 40. Serruys P. and Y. Onuma, 5-Year Cohort A and 2- Year Cohort B Results: Integrated Insights, in TCT 2011: San Francisco.
- 41. Chevalier B. ABSORB Cohort B Trial: Evaluation of the ABSORB Bioresorbable Everolimus-Eluting Vascular Scaffold in the Treatment of Patients with de novo Native Coronary Artery Lesions. in American College of Cardiology. 2011. New Orleans.
- 42. Dudek D. ABSORB Cohort B Trial: Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de novo Native Coronary Artery Lesions - 2-Year Clinical Results in American College of Cardiology. 2012. Chicago.
- 43. Van Geuns, R.J. Preliminary data from ABSORB EXTEND: A report of the 6-month clinical outcomes from the first 269 patients registered, in EuroPCR Focus on BVS 2012, (presentation): Rotterdam, Netherlands.
- 44. Onuma, Y. and P. Serruys. Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? Circulation. 2011; 123: p. 779-797.
- 45. Koster R et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet, 2000. 356(9245): p. 1895-7.
- 46. Diletti R, Farooq V, Girasis C, et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart. 2013; 99: 98-105.
- 47. Muramatsu T, Onuma Y, Garcia-Garcia HM, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORBEXTEND single-arm trial in comparison with an everolimus- eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv. 2013; 6: 247-257.
- 48. Iqbal J, Onuma Y, Ormiston J et al. Bioresorbable coronary scaffolds: a novel device-based solution in search of its clinical need. Eur Heart J. 2014; 35: 753-757.
- 49. Serruys PW, Onuma Y, Garcia-Garcia HM et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014; in press.
- 50. Dilleti R, Serruys PW, Farooq V, et al. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, afficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-elu ting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Am Heart J. 2012; 164: 654-63.
DOI: https://doi.org/10.1515/prilozi-2015-0063 | Journal eISSN: 1857-8985 (formerly 0350-1914) | Journal ISSN: 1857-9345
Language: English, Russian
Page range: 147 - 155
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Related subjects:
© 2015 Jorgo Kostov, Jelka Davceva-Pavlovska, Sasko Kedev, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.